Brind.

Abbott Presents Positive Results for Coronary IVL System at TCT Conference

1 report, 1 independent Updated Sun 00:00
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Abbott presented results from the TECTONIC Coronary Artery Disease (CAD) Intravascular Lithotripsy (IVL) Investigational Device Exemption (IDE) Study at the Transcatheter Cardiovascular Therapeutics (TCT) conference in San Diego. The study evaluated the investigational SonicForce Coronary IVL System, which uses acoustic pressure waves to crack calcium buildup in coronary arteries. The results met primary safety and effectiveness endpoints and demonstrated excellent early clinical outcomes in patients with severe coronary calcification.

From prnewswire.com

Why it matters

Some supportBrind's analysis of the reports

The successful outcomes of the TECTONIC study could strengthen Abbott's comprehensive coronary devices portfolio. Approval of the investigational system would complement its existing advanced imaging, lesion preparation, and stent technologies.

From prnewswire.com

Who's involved

  • AbbottDeveloper of the investigational SonicForce Coronary IVL System

Who could feel it

Possible knock-on effects

These are possibilities Brind reasoned out, not predictions, and not advice. Most are not stated in any report.

  • AbbottSpeculative

    The successful adoption of the investigational system could increase demand for specialized medical procedures and devices.

Keep exploring

The entities involved

Related events

Coverage

Newest first; wire copies grouped